Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Candel Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:CADL | Benzinga

Q: What sector and industry does Candel Therapeutics (CADL) operate in?

Candel Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Explore Candel Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for CADL.

Open	$4.48
Close	$4.51
Volume / Avg.	385.55K / 1.12M
Day Range	$4.41 - $4.81
52 Wk Range	3.79 - 14.60
Market Cap	$214.45M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	33
Short Interest	12%
Days to Cover	3.51

Recent News

Candel Therapeutics Reports Prolonged Survival In Mid-Stage Study For Pretreated Lung Cancer Patients

Candel Therapeutics' CAN-2409 extended survival in NSCLC patients, with biomarker data showing enhanced response in non-squamous cases and a strong safety profile.

Vandana Singh

Candel Therapeutics Shares Are Down Today: What's Going On?

Candel Therapeutics, Inc. (NASDAQ: CADL) shares are are trading lower Thursday after the company released final survival data from its phase 2a clinical trial of CAN-2409.

Vaishali Prayag

This Palantir Technologies Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Nov 24

Dec 24

Feb

Mar

Apr

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.2

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$4.48
Close	$4.51
Volume / Avg.	385.55K / 1.12M
Day Range	$4.41 - $4.81
52 Wk Range	3.79 - 14.60
Market Cap	$214.45M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	33
Short Interest	12%
Days to Cover	3.51

About Candel Therapeutics Inc

Sector

Health Care

Industry

Biotechnology

Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and comm...

Got Questions? Ask

Compare CADL performance to the market?

What is CADL's all-time high price?

What is CADL's P/E ratio?

What is the Pivot support level for CADL?

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Candel Therapeutics (CADL) stock?

You can purchase shares of Candel Therapeutics (NASDAQ:CADL) through any online brokerage.

View our list of the best stock brokerages

Who are Candel Therapeutics (CADL) competitors?

Other companies in Candel Therapeutics’s space includes: Monopar Therapeutics (NASDAQ:MNPR), Anika Therapeutics (NASDAQ:ANIK), Abeona Therapeutics (NASDAQ:ABEO), Design Therapeutics (NASDAQ:DSGN) and Emergent BioSolutions (NYSE:EBS).

What is the forecast, or price target, for Candel Therapeutics (CADL) stock?

Candel Therapeutics has a consensus price target of $15.67.

What is the current price for Candel Therapeutics (CADL)?

The stock price for Candel Therapeutics (NASDAQ: CADL) is $4.54 last updated April 21, 2025 at 7:45 PM EDT.

Does Candel Therapeutics (CADL) pay a dividend?

There are no upcoming dividends for Candel Therapeutics.

When is Candel Therapeutics (NASDAQ:CADL) reporting earnings?

Candel Therapeutics’s Q1 earnings are confirmed for Tuesday, May 13, 2025.

Is Candel Therapeutics (CADL) going to split?

There is no upcoming split for Candel Therapeutics.

What sector and industry does Candel Therapeutics (CADL) operate in?

Candel Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Candel Therapeutics Stock Price, Quotes and Forecasts

Candel Therapeutics (CADL) Forecast